UK markets closed

VBI Vaccines Inc. (VBIV)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6300-0.0196 (-3.02%)
At close: 04:00PM EDT
0.6103 -0.02 (-3.13%)
After hours: 07:31PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.6496
Open0.6500
Bid0.5980 x 100
Ask0.6619 x 100
Day's range0.6200 - 0.6500
52-week range0.4500 - 3.4700
Volume143,315
Avg. volume431,700
Market cap18.07M
Beta (5Y monthly)1.89
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    VBI Vaccines Reports First Quarter 2024 Financial Results

    CAMBRIDGE, Mass., May 15, 2024--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the quarter ended March 31, 2024.

  • Business Wire

    VBI Vaccines Reports Full Year 2023 Financial Results

    CAMBRIDGE, Mass., April 16, 2024--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the year ended December 31, 2023.

  • Business Wire

    VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

    CAMBRIDGE, Mass., April 11, 2024--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 2,272,728 of its common shares and warrants to purchase up to 2,272,728 common shares, at an offering price of $0.88 per common share and associated warrant. The warrants have an exercise